The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Cardisan 1.25 mg chewable tablets for dogs



Alfasan Nederland B.VVPA10980/024/001

Main Information

Trade NameCardisan 1.25 mg chewable tablets for dogs
Active SubstancesPimobendan
Dosage FormChewable tablet
Licence HolderAlfasan Nederland B.V
License Holder AddressKuipersweg 9
3449 JA Woerden
Netherlands
Licence NumberVPA10980/024/001

Group Information

ATC CodeQC01CE90 pimobendan
Therapeutic ClassCardiovascular
SpeciesDogs

Status

License statusAuthorised
Licence Issued07/10/2022
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back